434 related articles for article (PubMed ID: 15608651)
1. Unique binding interactions among Ubc9, SUMO and RanBP2 reveal a mechanism for SUMO paralog selection.
Tatham MH; Kim S; Jaffray E; Song J; Chen Y; Hay RT
Nat Struct Mol Biol; 2005 Jan; 12(1):67-74. PubMed ID: 15608651
[TBL] [Abstract][Full Text] [Related]
2. Alternative allosteric mechanisms can regulate the substrate and E2 in SUMO conjugation.
Karaca E; Tozluoğlu M; Nussinov R; Haliloğlu T
J Mol Biol; 2011 Mar; 406(4):620-30. PubMed ID: 21216249
[TBL] [Abstract][Full Text] [Related]
3. Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex.
Reverter D; Lima CD
Nature; 2005 Jun; 435(7042):687-92. PubMed ID: 15931224
[TBL] [Abstract][Full Text] [Related]
4. A stable chemical SUMO1-Ubc9 conjugate specifically binds as a thioester mimic to the RanBP2-E3 ligase complex.
Sommer S; Ritterhoff T; Melchior F; Mootz HD
Chembiochem; 2015 May; 16(8):1183-9. PubMed ID: 25917782
[TBL] [Abstract][Full Text] [Related]
5. The RanBP2/RanGAP1*SUMO1/Ubc9 complex is a multisubunit SUMO E3 ligase.
Werner A; Flotho A; Melchior F
Mol Cell; 2012 May; 46(3):287-98. PubMed ID: 22464730
[TBL] [Abstract][Full Text] [Related]
6. Solution structure of human SUMO-3 C47S and its binding surface for Ubc9.
Ding H; Xu Y; Chen Q; Dai H; Tang Y; Wu J; Shi Y
Biochemistry; 2005 Mar; 44(8):2790-9. PubMed ID: 15723523
[TBL] [Abstract][Full Text] [Related]
7. Reconstitution of the Recombinant RanBP2 SUMO E3 Ligase Complex.
Ritterhoff T; Das H; Hao Y; Sakin V; Flotho A; Werner A; Melchior F
Methods Mol Biol; 2016; 1475():41-54. PubMed ID: 27631796
[TBL] [Abstract][Full Text] [Related]
8. Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation.
Tatham MH; Kim S; Yu B; Jaffray E; Song J; Zheng J; Rodriguez MS; Hay RT; Chen Y
Biochemistry; 2003 Aug; 42(33):9959-69. PubMed ID: 12924945
[TBL] [Abstract][Full Text] [Related]
9. Ubc9 sumoylation regulates SUMO target discrimination.
Knipscheer P; Flotho A; Klug H; Olsen JV; van Dijk WJ; Fish A; Johnson ES; Mann M; Sixma TK; Pichler A
Mol Cell; 2008 Aug; 31(3):371-82. PubMed ID: 18691969
[TBL] [Abstract][Full Text] [Related]
10. Determinants of small ubiquitin-like modifier 1 (SUMO1) protein specificity, E3 ligase, and SUMO-RanGAP1 binding activities of nucleoporin RanBP2.
Gareau JR; Reverter D; Lima CD
J Biol Chem; 2012 Feb; 287(7):4740-51. PubMed ID: 22194619
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of UBA2(ufd)-Ubc9: insights into E1-E2 interactions in Sumo pathways.
Wang J; Taherbhoy AM; Hunt HW; Seyedin SN; Miller DW; Miller DJ; Huang DT; Schulman BA
PLoS One; 2010 Dec; 5(12):e15805. PubMed ID: 21209884
[TBL] [Abstract][Full Text] [Related]
12. Performing in vitro sumoylation reactions using recombinant enzymes.
Werner A; Moutty MC; Möller U; Melchior F
Methods Mol Biol; 2009; 497():187-99. PubMed ID: 19107418
[TBL] [Abstract][Full Text] [Related]
13. Structural basis for SUMO-E2 interaction revealed by a complex model using docking approach in combination with NMR data.
Ding H; Yang Y; Zhang J; Wu J; Liu H; Shi Y
Proteins; 2005 Dec; 61(4):1050-8. PubMed ID: 16224784
[TBL] [Abstract][Full Text] [Related]
14. The RanBP2/RanGAP1*SUMO1/Ubc9 SUMO E3 ligase is a disassembly machine for Crm1-dependent nuclear export complexes.
Ritterhoff T; Das H; Hofhaus G; Schröder RR; Flotho A; Melchior F
Nat Commun; 2016 May; 7():11482. PubMed ID: 27160050
[TBL] [Abstract][Full Text] [Related]
15. The RanBP2 SUMO E3 ligase is neither HECT- nor RING-type.
Pichler A; Knipscheer P; Saitoh H; Sixma TK; Melchior F
Nat Struct Mol Biol; 2004 Oct; 11(10):984-91. PubMed ID: 15378033
[TBL] [Abstract][Full Text] [Related]
16. Protein interactions in the sumoylation cascade: lessons from X-ray structures.
Tang Z; Hecker CM; Scheschonka A; Betz H
FEBS J; 2008 Jun; 275(12):3003-15. PubMed ID: 18492068
[TBL] [Abstract][Full Text] [Related]
17. Identification of a non-covalent ternary complex formed by PIAS1, SUMO1, and UBC9 proteins involved in transcriptional regulation.
Mascle XH; Lussier-Price M; Cappadocia L; Estephan P; Raiola L; Omichinski JG; Aubry M
J Biol Chem; 2013 Dec; 288(51):36312-27. PubMed ID: 24174529
[TBL] [Abstract][Full Text] [Related]
18. Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation.
Wiechmann S; Gärtner A; Kniss A; Stengl A; Behrends C; Rogov VV; Rodriguez MS; Dötsch V; Müller S; Ernst A
J Biol Chem; 2017 Sep; 292(37):15340-15351. PubMed ID: 28784659
[TBL] [Abstract][Full Text] [Related]
19. Perturbation of SUMOlation enzyme Ubc9 by distinct domain within nucleoporin RanBP2/Nup358.
Saitoh H; Pizzi MD; Wang J
J Biol Chem; 2002 Feb; 277(7):4755-63. PubMed ID: 11709548
[TBL] [Abstract][Full Text] [Related]
20. Fourier transform ion cyclotron resonance mass spectrometry for the analysis of small ubiquitin-like modifier (SUMO) modification: identification of lysines in RanBP2 and SUMO targeted for modification during the E3 autoSUMOylation reaction.
Cooper HJ; Tatham MH; Jaffray E; Heath JK; Lam TT; Marshall AG; Hay RT
Anal Chem; 2005 Oct; 77(19):6310-9. PubMed ID: 16194093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
